FY total loss was CHF 18.6M, primarily driven by R&D expenditures of CHF 12.7M.Spexis’ cash position as of December 31, 2022 was CHF 1.8M.
Read Full Story at source (may require registration)
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024
- FTSE 100 Modestly Higher In Cautious Trade - November 27, 2024
- CAC 40 Slides As French Risk Premium Peaks - November 27, 2024